Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-05-14Clinical Trial Update: MabionCD20® Compared to MabThera® in Patients With Rheumatoid Arthritis [Phase 3]
Phase 3 clinical trial comparing MabionCD20 to MabThera in rheumatoid arthritis has been completed.
-
FDA approval · 2020-05-08FDA Approved: IBUPROFEN — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's ibuprofen generic under Original Application (ANDA213794). The product is a generic version of ibupr…
-
CLINICAL_TRIALS research · 2020-04-27Clinical Trial Update: Effect of Sarilumab on Atherosclerotic Disease Assessed by PET/CET in Patients With RA (SARIPET) [Phase 4]
Clinical trial update investigating the effect of sarilumab on atherosclerotic disease in patients with rheumatoid arthritis, assessed by PE…
-
CLINICAL_TRIALS trial_result · 2020-04-10Clinical Trial Update: Comparison of the Effectiveness of Two Different Dosages of Cortisone Compared to Placebo in Rheumatoid Arthritis [Phase 3]
Phase 3 trial comparing two cortisone dosages to placebo in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-10Clinical Trial Update: Comparative Analysis of Adherence and Effectiveness Outcomes Between Rheumatoid Arthritis (RA) Patients Treated With Tofacitinib Modified Release (MR)
Completed clinical trial evaluating adherence and effectiveness of tofacitinib modified release in rheumatoid arthritis with results posted …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-04-09FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for hydroxychloroquine sulfate from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: A Phase I/III Study to Evaluate Efficacy, PK and Safety Between CT-P13 SC and CT-P13 IV in Patients With Active RA [Phase 3]
Phase I/III trial comparing subcutaneous CT-P13 to intravenous CT-P13 in active rheumatoid arthritis has completed with posted results.
-
FDA approval · 2020-04-01FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for hydroxychloroquine sulfate from Aurobindo Pharma Limited.
-
FDA approval · 2020-04-01FDA Approved: ARTHRITIS PAIN RELIEVER — Supplemental Application (Publix Super Markets Inc)
FDA approved a supplemental application for Publix Super Markets Inc's arthritis pain reliever containing diclofenac sodium under an ANDA.
-
FDA approval · 2020-04-01FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Creekwood Pharmaceuticals LLC)
The FDA approved Creekwood Pharmaceuticals LLC's supplemental application for hydroxychloroquine sulfate, authorizing the continued marketin…
-
FDA label_change · 2020-03-31FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Ipca Laboratories Limited)
FDA approved a supplemental application for hydroxychloroquine sulfate from Ipca Laboratories Limited, resulting in changes to the drug's la…
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: The Effects of Hyperbaric Oxygen on Rheumatoid Arthritis [NA]
Completed clinical trial evaluating the effects of hyperbaric oxygen on rheumatoid arthritis; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis [Phase 4]
Phase 4 study updating safety and effectiveness of Acthar Gel in participants with rheumatoid arthritis.
-
FDA approval · 2020-03-19FDA Approved: NAPROXEN — Supplemental Application (Aurobindo Pharma Limited)
FDA approves Aurobindo Pharma Limited's supplemental application for naproxen (generic) under ANDA075390. This action constitutes a suppleme…
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: CMAB008 With MTX Therapy in Adult Patients With Moderately to Severely Active Rheumatoid Arthritis [Phase 3]
Phase 3 trial update for CMAB008 in combination with methotrexate in adults with moderately to severely active rheumatoid arthritis has comp…
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: A Study to Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDs [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of ASP015K in rheumatoid arthritis patients with an inadequate response to DMARDs has com…
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Prediction of Response to Certolizumab Pegol Treatment by Functional MRI of the Brain [Phase 3]
Phase 3 trial update examining prediction of response to certolizumab pegol in rheumatoid arthritis using functional MRI of the brain.
-
FDA approval · 2020-03-06FDA Approved: CELECOXIB — Original Application (Chartwell RX, LLC)
FDA approved the original generic application for celecoxib (Celecoxib) by Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2020-03-02Clinical Trial Update: A Study to Target the Type I IFN Receptor by Administrating Anifrolumab in RA Patients With a High IFN Signature (TarIFNiRA) [Phase 2]
Phase 2 clinical trial investigating anifrolumab targeting Type I IFN receptor in rheumatoid arthritis patients with high IFN signature.
-
CLINICAL_TRIALS trial_result · 2020-02-27Clinical Trial Update: Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To Methotrexate [Phase 2]
Phase 2 trial assessing safety and efficacy of Pf-06650833 in rheumatoid arthritis patients with inadequate response to methotrexate; study …
-
FDA approval · 2020-02-25FDA Approved: CELECOXIB — Original Application (EPIC PHARMA, LLC)
FDA approved the Original Application (ANDA) for a generic Celecoxib product from Epic Pharma, LLC, enabling its marketing as a COX-2 inhibi…
-
FDA approval · 2020-02-19FDA Approved: DICLOFENAC SODIUM MISOPROSTOL — Original Application (Nivagen Pharmaceuticals, Inc.)
FDA approved the original application for diclofenac sodium and misoprostol, a generic diclofenac/misoprostol combination product manufactur…
-
FDA approval · 2020-02-18FDA Approved: NAPROXEN AND ESOMEPRAZOLE MAGNESIUM — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited for Naproxen and Esomeprazole Magnesium under an Original Application (ANDA) for a generic Nap…
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: PK, PD, Safety, and Efficacy of SAIT101 Versus MabThera® Versus Rituxan® in Patients With Rheumatoid Arthritis [Phase 1]
Phase 1 trial comparing SAIT101 with MabThera/Rituxan in rheumatoid arthritis completed with posted results.
-
FDA approval · 2020-02-14FDA Approved: VOLTAREN ARTHRITIS PAIN — Supplemental Application (Haleon US Holdings LLC)
FDA approves a supplemental application for Voltaren Arthritis Pain (diclofenac sodium) by Haleon US Holdings LLC to expand the labeling for…